Website Header with Language Selector and Dropdowns
Watermark

Asenapine Impurity 9


Catalog Number: CL-ASI-19
CAS No.: 1180843-76-8
Mol.F: C18H18ClNO4
Mol.W: 347.8
Inv. Status: Custom Synthesis

Chemical Name: Methyl N-(2-(5-chloro-2-phenoxyphenyl)acetyl)-N-methylglycinate.

Country of Origin: India

Product Category: Asenapine Impurities


Asenapine Impurity 9 is identified by CAS No. 1180843-76-8 and is chemically known as Methyl N-(2-(5-chloro-2-phenoxyphenyl)acetyl)-N-methylglycinate.

Asenapine Impurity 9 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Page Keywords: Buy Asenapine Impurity 9 | Purchase Asenapine Impurity 9 | Asenapine Impurity 9 suppliers | Asenapine Impurity 9 manufacturers | Asenapine Impurity 9 price | Asenapine Impurity 9 Importer | Asenapine Impurity 9 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-ASI-01
CAS No: 65576-45-6
Mol Wt: 285.8
Mol F: C17H16ClNO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-04
CAS No: 1262639-38-2
Mol Wt: 301.8
Mol F: C17H16ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-05
CAS No: 1399103-21-9
Mol Wt: 381.8
Mol F: C17H16ClNO5S
Inv. Status: Custom Synthesis
CAT No: CL-ASI-10
CAS No: 129385-59-7
Mol Wt: 299.8
Mol F: C17H14ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-20
CAS No: 1162120-35-5
Mol Wt: 315.8
Mol F: C17H14ClNO3
Inv. Status: Custom Synthesis
CAT No: CL-ASI-21
CAS No: 13515-93-0
Mol Wt: 103.1 : 36.5
Mol F: C4H9NO2 : HCl
Inv. Status: Custom Synthesis
CAT No: CL-ASI-22
CAS No: 165890-26-6
Mol Wt: 299.8
Mol F: C17H14ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-23
CAS No: 1012884-46-6
Mol Wt: 297.7
Mol F: C17H12ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-24
CAS No: NA
Mol Wt: 299.8
Mol F: C17H14ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-25
CAS No: NA
Mol Wt: 315.8
Mol F: C17H14ClNO3
Inv. Status: Custom Synthesis
CAT No: CL-ASI-26
CAS No: NA
Mol Wt: 315.8
Mol F: C17H14ClNO3
Inv. Status: Custom Synthesis
CAT No: CL-ASI-27
CAS No: 912355-99-8
Mol Wt: 317.8
Mol F: C17H16ClNO3
Inv. Status: Custom Synthesis
CAT No: CL-ASI-28
CAS No: NA
Mol Wt: 297.7
Mol F: C17H12ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-11
CAS No: NA
Mol Wt: C17H18ClNO : HBr
Mol F: C17H18ClNO : HBr
Inv. Status: Custom Synthesis
CAT No: CL-ASI-29
CAS No: 1431973-29-3
Mol Wt: 419.3
Mol F: C19H19BrN2O4
Inv. Status: Custom Synthesis
CAT No: CL-ASI-30
CAS No: 1688678-58-1
Mol Wt: 296.3 : 116.1
Mol F: C17H16N2O3 : C4H4O4
Inv. Status: Custom Synthesis
CAT No: CL-ASI-12
CAS No: 1847487-56-2
Mol Wt: 251.3
Mol F: C17H17NO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-13
CAS No: 128915-56-0
Mol Wt: 271.7
Mol F: C16H14ClNO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-14
CAS No: 1422571-39-8
Mol Wt: 285.8
Mol F: C17H16ClNO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-16
CAS No: 2476-37-1
Mol Wt: 189
Mol F: C8H6Cl2O
Inv. Status: Custom Synthesis
CAT No: CL-ASI-17
CAS No: 70958-18-8
Mol Wt: 246.7
Mol F: C14H11ClO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-18
CAS No: 70958-20-2
Mol Wt: 262.7
Mol F: C14H11ClO3
Inv. Status: Custom Synthesis
CAT No: CL-ASI-06
CAS No: 934996-79-9
Mol Wt: 297.7
Mol F: C17H12ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-07
CAS No:  1170701-78-6
Mol Wt: 271.7 : 36.5
Mol F: C16H14ClNO : HCl
Inv. Status: Custom Synthesis
CAT No: CL-ASI-03
CAS No: NA
Mol Wt: 301.8
Mol F: C17H16ClNO2
Inv. Status: Custom Synthesis
CAT No: CL-ASI-15
CAS No: 1688678-60-5
Mol Wt: 266.3 : 116.1
Mol F: C17H18N2O : C4H4O4
Inv. Status: Custom Synthesis
CAT No: CL-ASI-08
CAS No: 129385-60-0
Mol Wt: 281.7
Mol F: C17H12ClNO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-02
CAS No:  65621-78-5
Mol Wt: 285.8
Mol F: C17H16ClNO
Inv. Status: Custom Synthesis
CAT No: CL-ASI-09
CAS No: 65576-39-8
Mol Wt: 251.3
Mol F: C17H17NO
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.